Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Exscientia Plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Exscientia Presents Three Posters Demonstrating Potential of Precision Medicine Platform in Drug Discovery at the American Association of Cancer Research Annual Meeting 2022
From Exscientia plc
Via Business Wire
News headline image
Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer
From Exscientia
Via Business Wire
News headline image
Exscientia Business Update for Fourth Quarter and Full Year 2021
From Exscientia plc
Via Business Wire
News headline image
Exscientia to Report Fourth Quarter and Year End 2021 Financial Results on March 23, 2022
From Exscientia
Via Business Wire
News headline image
Exscientia to Present at Upcoming Investor Conferences in March
From Exscientia
Via Business Wire
News headline image
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
From Exscientia
Via Business Wire
News headline image
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines
From Exscientia
Via Business Wire
News headline image
Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
From Exscientia
Via Business Wire
News headline image
Exscientia Business Update for Third Quarter 2021
From Exscientia
Via Business Wire
News headline image
Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021
From Exscientia
Via Business Wire
News headline image
Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes
From Exscientia
Via Business Wire
News headline image
Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters’ Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement
From Exscientia
Via Business Wire
News headline image
Exscientia Announces Pricing of $304.7 Million Upsized Initial Public Offering and $160.0 Million Concurrent Private Placements
From Exscientia plc Exscientia
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.